Building a World-Class Synthetic Biology Lab: Asymchem's Self-Developed STAR System Empowers Protein Design

Businesswire11:00 ET

Why Asymchem Laboratories (Tianjin)'s (SZSE:002821) Shaky Earnings Are Just The Beginning Of Its Problems

Simply Wall StNov 5 18:08 ET

Hong Kong stocks are active | CRO concepts generally rise, medical insurance negotiations support innovative drugs, and under the environment of interest rate cuts, global biomedical financing will rebound.

The concept of CRO is generally on the rise. As of the time of publication, Asymchem Laboratories (06821) rose by 4.95%, to HKD 59.4; Tigermed (03347) rose by 4.94%, to HKD 38.25; Wuxi Apptec (02359) rose by 3.88%, to HKD 53.5.

Zhitong FinanceNov 5 01:34 ET

Hong Kong stock concept tracking | The end of medical insurance negotiations is very encouraging for innovative drugs to be included in medical insurance at reasonable prices (with concept stocks)

The on-site negotiation and bidding stages for the adjustment of the national medical insurance pharmaceutical catalog in 2024 officially ended recently.

Zhitong FinanceNov 3 20:45 ET

Historically the most 'competitive'? The Tenth Batch of National Procurement Pharmaceutical Catalog Is Officially Announced with one type having up to 31 companies competing.

①This afternoon, the National Pharmaceutical Joint Procurement Office officially announced the tenth batch of nationally purchased pharmaceutical catalog, with a total of 263 specifications and 62 varieties; ②Several industry insiders have stated that the tenth batch of national procurement will be the largest and most competitive national procurement in history.

cls.cnNov 1 08:59 ET

Asymchem Laboratories (002821.SZ): cumulatively repurchased 3.5976% of shares.

On November 1st, GeLongHui reported that as of October 31, 2024, Asymchem Laboratories (002821.SZ) announced the cumulative repurchase of company shares through a repurchase special securities account in a centralized bidding manner, with a total of 12,300,701 shares repurchased, accounting for 3.5976% of the company's A-share total share capital. The highest fill price was 102.00 yuan per share, the lowest fill price was 71.65 yuan per share, with a total amount paid of 999,644,601.56 yuan (excluding transaction fees). The repurchase of shares this time complies with the company's repurchase plan and relevant legal requirements.

Gelonghui FinanceNov 1 05:16 ET